Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
13 - 24 of 159 Results
Sort by:
Best Match

Optical and microCT imaging enables noninvasive monitoring of EBV-induced neuroinvasion
Researchers use optical and microCT imaging to noninvasively monitor EBV-induced neuroinvasion in a mouse model.

IVIS Lumina X5 product note
High-sensitivity 2D optical meets high-resolution x-ray with the IVIS Lumina X5 benchtop imaging system.

IVIS Spectrum Product note
2D and 3D preclinical optical imaging with the industry-leading IVIS® Spectrum system.

IVIS SpectrumCT product note
The IVIS SpectrumCT bioluminescence and fluorescence preclinical imaging system with integrated CT.

Development of an AlphaLISA assay to measure and screen inhibitors of the p53-MDM2 interaction
Development of an AlphaLISA Assay to Measure and Screen Inhibitors of the p53-MDM2 Interaction

Dual NIR imaging of β-Amyloid plaques and Tau tangles provides potential insights into Alzheimer’s disease
The use of Dual NIR Imaging of β-Amyloid Plaques and Tau Tangles to provide Potential Insights into Alzheimer’s Disease

Signaling in the immune system - HTRF assays for oncology and inflammation
A summary of signaling pathways in the immune system.

Effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in high-content analysis screening experiments
Find out about the effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in HCA screening experiments.

Pooled phenotypic CRISPR screening enables the identification of synergistic drug combinations for cancer therapy
This application note demonstrates how a pooled phenotypic CRISPR screening can be used to identify synergistic drug combinations for cancer therapy

Linking genes to phenotypes with CRISPR screening
Literature review on the multiple CRIPSR screening techniques available for drug discovery and their benefits.

Overcoming hurdles in high-throughput profiling of cancer cell responses
Presenting case studies on how functional genomic screening is used to find therapeutic targets, identify patient populations, uncover MoA, investigate drug combinations, and reveal drug resistance and sensitivity

CRISPR-Cas9 screening: a powerful approach to advance drug discovery
Find out about the potential of CRISPR-Cas9 screening for drug discovery in this white paper.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.